Cone Rod Dystrophy: Clinical Trials

7 trials for Cone Rod Dystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 completed, 1 active not recruiting, 1 terminated. 2 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Cone Rod Dystrophy: new trials by email Literature Review of Cone Rod Dystrophy trials Research Report on Cone Rod Dystrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Transcorneal Electrical Stimulation using the OkuStim System - Retinitis Pigmentosa (RP), Usher Syndrome
RecruitingOkuvision GmbH302026-04-202026-05-01
Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Prescreening Assessments - Stargardt Disease, Stargardt Disease 1
RecruitingAscidian Therapeutics, Inc502024-06-202026-10-09
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
ACDN-01 - Stargardt Disease, Cone Rod Dystrophy
Phase 1 / Phase 2Active not recruitingAscidian Therapeutics, Inc152024-06-112026-11-10
Adaptive Optics Imaging of Outer Retinal Diseases
Adaptive optics imaging - Retinal Degeneration, Age-Related Macular Degeneration
RecruitingFood and Drug Administration (FDA)1002021-08-272026-05-08
Study of New Mutations in Cone Disorders
Blood and/or skin biopsy - Retinal Dystrophy, Cone-Rod, Cone Dystrophy
TerminatedUniversity Hospital, Lille72021-03-032026-05-22
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy
Intelligent Retinal Implant System - Retinitis Pigmentosa, Cone Rod Dystrophy
Not applicableCompletedScience Corporation102016-01-012019-05-29
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy
Intelligent Retinal Implant System - Retinitis Pigmentosa, Cone Rod Dystrophy
Not applicableCompletedScience Corporation202013-04-012017-10-17

Narrower conditions

Cone-Rod Dystrophies (7)  ·  Retinitis Pigmentosa (4)  ·  Choroideremia (2)  ·  Cone Dystrophy (2)  ·  Macular Degeneration (2)  ·  Retinal Degeneration (2)  ·  Retinal Dystrophies (2)  ·  Stargardt Disease (2)  ·  Usher Syndromes (2)  ·  Eye Diseases (1)  ·  Late-Onset Retinal Degeneration (1)  ·  Retinal Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Eye Diseases, Hereditary (7)  ·  Genetic Diseases, Inborn (7)  ·  Eye Diseases (6)  ·  Retinal Diseases (6)  ·  Retinal Degeneration (5)  ·  Retinal Dystrophies (5)  ·  Abnormalities, Multiple (2)  ·  Blindness (2)  ·  Choroid Diseases (2)  ·  Congenital Abnormalities (2)  ·  Deaf-Blind Disorders (2)  ·  Deafness (2)  ·  Ear Diseases (2)  ·  Genetic Diseases, X-Linked (2)

Sponsors

Ascidian Therapeutics, Inc (2)  ·  Science Corporation (2)  ·  Food and Drug Administration (FDA) (1)  ·  Okuvision GmbH (1)  ·  University Hospital, Lille (1)

Countries

France (3)  ·  Germany (3)  ·  United States (3)  ·  Austria (2)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Murray Abramson, MD, PhD (2)  ·  Daniel X Hammer, Ph.D. (1)

Results publications

PMID 39281698